Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1144-1151

  Tomita, Ken ^a   Araie, Makoto ^b   Tamaki, Yasuhiro ^c   Nagahara, Miyuki ^b   Sugiyama, Tetsuya ^d  

^a TOKYO KOSEI NENKIN HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; NILVADIPINE; PLACEBO; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; CHOROID PLEXUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HUMAN; LASER DOPPLER FLOWMETRY; NERVE STIMULATION; NONHUMAN; OPTIC NERVE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULSE RATE; QUANTITATIVE DIAGNOSIS; RABBIT; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW;

ADULT; AGED; ANIMALS; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; EYE; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NIFEDIPINE; OPTIC DISK; RABBITS; REFERENCE VALUES; REGIONAL BLOOD FLOW;

EID: 0032924927     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fechtner R, Weinreb RN. Mechanism of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994;39:23-42.
2. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38(suppl):S3-S6.
3. Cohn JN. Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Ann Intern Med. 1983;98(pt 2):806-809.
4. Hof RP. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol. 1983;78:375-394.
5. Ohtsuka M, Yokota M, Kodama I, Yamada K, Shibata S. New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen Pharmacol. 1989; 20:539-556.
6. 2+-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:408-412.
7. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608-613.
8. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma. Ophthalmology. 1995; 102:1236-1241.
9. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996;103:283-288.
10. Takenaka T, Handa J. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. Int J Clin Pharmacol Ther Toxicol. 1979;17:1-11.
11. Harino S, Riva CE, Petrig BL. Intravenous nicardipine in cats increases optic nerve head, but not retinal blood flow. Invest Ophthalmol Vis Sci. 1992;33:2885-2890.
12. Ohtsuka M, Ono T, Hiroi J, Esumi K, Kikuchi H, Kumada S. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists. J Cardiovasc Pharmacol. 1983;5:1074-1082.
13. Ohtsuka M, Koibuchi Y, Sakai S, et al. Effects of nilvadipine on the cardiovascular system in experimental animals. Arzneim-Forsch/ Drug Res. 1988;38:1605-1618.
14. Ohtsuka M, Ono T, Shibayama F. Nilvadipine. Cardiovasc Drug Rev. 1988;6:97-115.
15. Shimamoto H, Shimamoto Y. Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine. J Hum Hypertens. 1995;9:271-279.
16. Imai J, Omata K, Kamizuki M, et al.. Antihypertensive effects of nilvadipine determined by ambulatory blood pressure monitoring. Ther Res. 1996;17:1847-1856.
17. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1994: 3825-3834.
18. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60:373-374.
19. Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A, Fujii H. Real-time measurement of human optic nerve head and choroid circulation, using laser speckle phenomenon. Jpn J Ophthalmol. 1997;41:49-54.
20. Fercher AF, Briers JD. Flow visualization by means of single exposure speckle photography. Opt Commun. 1981;37:326-330.
21. Nagahara M, Tamaki Y, Araie M, Fujii H. Measurements of blood flow velocity in human retinal veins using laser speckle flowgraphy system. J Jpn Ophthalmol Soc (Nippon Ganka Gakkai Zasshi). 1997;102:173-179.
22. Kozuma C, Macklin W, Cummins LM, Mauer R. Anatomy, physiology, and biochemistry of the rabbit. In: Weisbroth SH, Flatt RE, Kraus AL, eds. The Biology of the Laboratory Rabbit. New York: Academic Press; 1974:50-72.
23. Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol. 1996;40:339-343.
24. Tamaki Y, Araie M, Tomita K, Tomidokoro T. Time change of nicardipine effect on choroidal circulation in rabbit eyes. Curr Eye Res. 1996;15:543-548.
25. Alm A. Ocular circulation. In: Hart WM Jr, ed. Adler's Physiology of the Eye. 9th ed. St. Louis: Mosby-Year Book; 1992:198-227.
26. Grayson MC, Laties AM. Ocular localization of sodium fluorescein: effects of administration in rabbit and monkey. Arch Ophthalmol. 1971;85:600-609.
27. Caprioli J, Miller JM. Measurement of optic nerve blood flow with iodoantipyrine: limitations caused by diffusion from the choroid. Exp Eye Res. 1988;47:641-652.
28. Cunha-Vaz JG, Shakib M, Ashton N. Studies on the permeability of the blood-retinal barrier, 1: on the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol. 1966;50:441-453.
29. Loutzenhiser R, Hayashi K, Epstein M. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol. 1989;257:F561-F564.
30. Altura BM, Altura BT, Carella A, Turlapaty PDMV, Weinberg J. Vascular smooth muscle and general anesthetics. Fed Proc. 1980; 39:1584-1591.
31. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems, Part 2: cardiovascular system. Experimentia. 1986;42:292-297.
32. Tamaki Y, Araie M, Tomita K, Tomidokoro A. Time-course of changes in nicardipine effects on microcirculation in retina and optic nerve head in living rabbit eyes. Jpn J Ophthalmol. 1996;40:202-211.
33. Lum BKB, Lockwood RL, Brewster ME. Studies on the anticonvulsant activity of calcium channel blockers (abstract). Pharmacologist. 1993;35:187.
34. Koelle JS, Riva CE, Petrig BL, Cranstoun SD. Depth of tissue sampling in the optic nerve head using laser Doppler flowmetry. Lasers Med Sci. 1993;8:49-54.
35. Netland PA, Grosskreutz CL, Feke GT, Hart LJ. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am J Ophthalmol. 1995;119:694-700.
36. Netland PA, Feke GT, Konno S, Goger DG, Fujio N. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma. 1996;5:200-206.
37. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol 1980;24:621-664.
38. Hitchings RA. Low tension glaucoma - its place in modern glaucoma practice. Br J Ophthalmol. 1992;76:494-496.
39. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan - a nationwide glaucoma survey. Jpn J Ophthalmol. 1991;35:133-55.
40. Flammer J, Guthauser U, Mahler F. Do vasospasms help cause low tension glaucoma? Doc Ophthalmol Proc Series. 1987;49:397-399.
41. Gasser P, Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol. 1987;66:3-18.
42. Liu S, Araujo SV, Spaeth GL, Katz LJ, Smith M. Lack of effect of calcium channel blockers on open-angle glaucoma. J Glaucoma. 1996;5:187-190.